Calf skinfold measurements as a diagnostic tool for lipodystrophy syndromes: a cross-sectional study
Authors:
- Grayce Ellen da Cruz Paiva LimaGLGrayce Ellen da Cruz Paiva Lima
- Fabia Karine de Moura LopesFLFabia Karine de Moura Lopes
- Jessica Silveira AraújoJAJessica Silveira Araújo
- Natália Prado BorisNBNatália Prado Boris
- Virginia Oliveira FernandesVFVirginia Oliveira Fernandes
- Victor Rezende VerasVVVictor Rezende Veras
- Mayara Teixeira Alexandrino SalesMSMayara Teixeira Alexandrino Sales
- Lorena Taúsz Tavares RamosLRLorena Taúsz Tavares Ramos
- Amanda Caboclo FlorAFAmanda Caboclo Flor
- Ana Paula Dias Rangel MontenegroAMAna Paula Dias Rangel Montenegro
- Maria Helane Gurgel CasteloMCMaria Helane Gurgel Castelo
- Clarisse Mourao Melo PonteCPClarisse Mourao Melo Ponte
Open Access
- 10 October 2025
- journal article
- research article
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-9
Abstract
Background: Lipodystrophy syndromes (LS) are characterized by reduced body fat and associated metabolic complications, such as insulin resistance and diabetes. The diagnosis of LS can be challenging in clinical settings. Skinfold measurement and body composition assessment using DEXA are commonly used for screening and diagnosis. This study aimed to identify alternative easy-to-use body composition parameters for diagnosing LS in clinical settings. Methods: This cross-sectional study included patients with genetically confirmed congenital generalized lipodystrophy (CGL) and familial partial lipodystrophy (FPL), with 62 matched healthy controls. Comprehensive data, including medical history, body composition, laboratory measurements, and imaging parameters, were collected. The receiver operating characteristic (ROC) curve was constructed using genetic test results, the gold standard for diagnosing genetic lipodystrophy, as the reference, and the sensitivity and specificity of calf skinfold measurements were measured with those of the genetic tests. Results: We included 62 patients with a mean age of 32 ± 18 (2–68) years, of whom 69.3% were women. The prevalence of diabetes mellitus (70%) and hypertriglyceridemia (83%) were also high. All body composition parameters significantly differed, except for calf skinfold measurements, which were similar between the CGL and FPL patients (p = 0.270). The ROC curve analysis identified a new cutoff point for calf skinfold measurement of <8 mm, with high diagnostic accuracy. Conclusions: This study identified calf skinfold measurements <8 mm as an accurate diagnostic tool for CGL and FPL. Notably, clinical accessibility to calf skinfold will favor its widespread use, standardization, and inclusion in physical examination protocols, improving lipodystrophy detection and diagnosis.Keywords
This publication has 26 references indexed in Scilit:
- One‐year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromesDiabetes, Obesity and Metabolism, 2015
- Congenital generalized lipodystrophies—new insights into metabolic dysfunctionNature Reviews Endocrinology, 2015
- The Clinical Approach to the Detection of Lipodystrophy an Aace Consensus StatementEndocrine Practice, 2013
- Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluationDiabetology & Metabolic Syndrome, 2012
- Human Lipodystrophies: Genetic and Acquired Diseases of Adipose Tissue2010
- HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)Archives of Endocrinology and Metabolism, 2009
- Genetic Disorders of Adipose Tissue Development, Differentiation, and DeathAnnual Review of Genomics and Human Genetics, 2006
- The threshold value for insulin resistance (HOMA-IR) in an admixtured populationDiabetes Research and Clinical Practice, 2006
- Practical Assessment of Body CompositionThe Physician and Sportsmedicine, 1985
- Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetesHuman Genetics, 1975